Comments*

 
  • Diabetes & Obesity Discussion Group

    Diabetes and obesity are inextricably linked components in a global epidemic affecting as many as one-third of individuals in susceptible populations. According to the World Health Organization, there are more than one billion overweight adults at risk of type 2 diabetes, as well as other chronic diseases like cardiovascular disease, hypertension and stroke, and certain forms of cancer.

    The Diabetes & Obesity Discussion Group brings together experts from widely different disciplines that rarely collaborate, to stimulate new research initiatives and strategies for containing this health crisis. The group places great importance on informal interaction between bench scientists, clinical pharmacologists, representatives of public health organizations, industry leaders, and policy makers, owing to the multifactorial etiology of an epidemic affecting the entire human life-span.

  • Steering Committee

    Diana Berger, MD, MSc

    Diabetes Medical Specialist

    Christopher S. James, MD

    MLV

    John G. Kral, MD, PhD

    SUNY Downstate Medical Center

    Timothy E. McGraw, PhD

    Weill Medical College of Cornell University

    Andrew G. Swick, PhD

    Nutrition Research Initiative, UNC

    James F. Tobin, PhD

    Pfizer, Inc.


  • Sponsors

    • Pepsico
    • Novo Nordisk

    Mission Partner support for the Frontiers of Science program provided by:

    • Johnson & Johnson

    Get more information about how you can sponsor a discussion group.

    EmailPrint